However, when ectopically expressed in IBC cells, DCN overexpression or DCN protein treatment significantly affects the expression of E-cadherin and EGFR–ERK activity as well as the invasion and development of IBC tumors. Here, DCN is linked to inflammatory breast carcinoma.